Skip to content
stoqly
en

Popular

All languages

Figures come from SEC filings, which are in English. Company and industry names stay as filed.

$ USD

Popular

All currencies

Data is in US dollars, converted at the ECB reference rate of Oct 23, 2026.

COMPASS Pathways plc

CMPS Nasdaq Pharmaceutical Preparations Financials FY2019โ€“FY2025

Last close ยท Oct 23, 2026

$11.18

3.9%
Compare
Revenue Total sales reported in the income statement.
โ€”
vs prior year
Operating margin Operating income as a share of revenue.
โ€”
Net income Profit after all expenses, interest and tax.
โˆ’$288M
Free cash flow Cash from operations minus capital spending.
โ€”
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โ€”
Market cap Last close times the latest diluted share count, so it is approximate.
$1.5B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
โ€”
On โˆ’$4.61 EPS (TTM)

What COMPASS Pathways plc does

No business description yet.

Legal name
COMPASS Pathways plc
Fiscal year ends
December 31, 2025
Latest annual report
10-K ยท Mar 24, 2026
Accession ยท CIK
0001816590-26-000020
0001816590

Revenue and margins

COMPASS Pathways plc had โ€” of revenue in fiscal 2025.

Revenue
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was โ€” in fiscal 2025, โ€” of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

COMPASS Pathways plc returned โ€” to shareholders in fiscal 2025. The diluted share count rose 38.6%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably COMPASS Pathways plc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $273M$143M$220M$165M$150M
Debt incl. finance leases โ€”$0.0M$28.8M$35.7M$49.2M
Debt / equity โ€”0.0x0.1x0.2xโ€”
Interest coverage โ€”โ€”โˆ’62.1xโˆ’39.8xโˆ’39.6x
Current ratio 19.5x12.3x13.3x5.9x0.8x
Quick ratio 19.5x12.3x13.3x5.9x0.8x
Total assets $301M$197M$276M$214M$210M
Total liabilities $16.5M$16.0M$50.2M$59.0M$263M
Shareholders' equity $284M$181M$226M$155Mโˆ’$52.8M
Net debt (โˆ’ = net cash) โ€”โˆ’$143Mโˆ’$191Mโˆ’$129Mโˆ’$100M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โ€œPlanโ€ marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

โ€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8โ€“9 is strong, 0โ€“2 weak.

TestFY19FY20FY21FY22FY23FY24FY25
Net income is positive โœ• โœ• โœ• โœ• โœ• โœ• โœ•
Cash from operations is positive โœ• โœ• โœ• โœ• โœ• โœ• โœ•
Return on assets rose โ€” โ€” โœ“ โœ• โœ“ โœ• โœ•
Cash from operations exceeds net income โœ“ โœ“ โœ“ โœ• โœ“ โœ“ โœ“
Debt fell relative to assets โ€” โ€” โ€” โ€” โœ• โœ• โœ•
Current ratio rose โ€” โ€” โœ• โœ• โœ“ โœ• โœ•
Share count didn't rise โ€” โœ• โœ• โœ• โœ• โœ• โœ•
Gross margin rose โ€” โ€” โ€” โ€” โ€” โ€” โ€”
Revenue rose relative to assets โ€” โ€” โ€” โ€” โ€” โ€” โ€”
F-score โ€” / 3โ€” / 4โ€” / 6โ€” / 63 / 71 / 71 / 7
Accruals ratio โ€”โˆ’9.3%โˆ’1.6%5.6%โˆ’8.9%โˆ’14.7%โˆ’61.6%
Altman Z'' โ€”32.9720.539.662.64โˆ’5.87โˆ’20.44

7 years of figures

Amounts in USD. Hover a ratioโ€™s name for its definition.

Download CSV
Fiscal yearFY19FY20FY21FY22FY23FY24FY25
Income statement
Research and development $12.6M $23.4M $44.0M $65.1M $87.5M $119M $118M
Operating income โˆ’$21.2M โˆ’$51.4M โˆ’$83.2M โˆ’$110M โˆ’$137M โˆ’$178M โˆ’$179M
Interest expense โ€” โ€” $0.0M $0.0M $2.2M $4.5M $4.5M
Pretax income โˆ’$19.6M โˆ’$60.3M โˆ’$71.5M โˆ’$91.1M โˆ’$118M โˆ’$154M โˆ’$290M
Income tax $0.0M $0.0M $0.2M $0.4M $0.8M $1.6M โˆ’$2.5M
Net income โˆ’$19.6M โˆ’$60.3M โˆ’$71.7M โˆ’$91.5M โˆ’$118M โˆ’$155M โˆ’$288M
Net income to common โ€” โˆ’$60.3M โˆ’$71.7M โˆ’$91.5M โˆ’$118M โ€” โ€”
Diluted EPS โˆ’$2.62 โˆ’$3.55 โˆ’$1.79 โˆ’$2.16 โˆ’$2.32 โˆ’$2.30 โˆ’$3.08
Diluted shares 0.01B 0.02B 0.04B 0.04B 0.05B 0.07B 0.09B
Cash flow
Cash from operations โˆ’$17.8M โˆ’$41.4M โˆ’$67.7M โˆ’$105M โˆ’$97.4M โˆ’$119M โˆ’$157M
Capital expenditure $0.2M $0.1M $0.3M $0.6M $0.1M $0.0M โ€”
Free cash flow โˆ’$18.0M โˆ’$41.5M โˆ’$68.1M โˆ’$106M โˆ’$97.4M โˆ’$119M โ€”
Depreciation and amortization $0.1M $0.1M $0.2M $0.3M $0.2M $0.2M $0.2M
Stock-based compensation $3.3M $18.0M $8.6M $13.1M $17.3M $19.5M $13.6M
Balance sheet
Cash and short-term investments $25.0M $190M $273M $143M $220M $165M $150M
Total debt โ€” โ€” โ€” $0.0M $28.8M $35.7M $49.2M
Current assets โ€” $202M $295M $192M $261M $201M $191M
Current liabilities โ€” $6.9M $15.1M $15.6M $19.6M $34.0M $248M
Property and equipment, net โ€” $0.2M $0.4M $0.6M $0.4M $0.2M โ€”
Total assets โ€” $203M $301M $197M $276M $214M $210M
Total liabilities โ€” $6.9M $16.5M $16.0M $50.2M $59.0M $263M
Shareholders' equity โˆ’$30.4M $197M $284M $181M $226M $155M โˆ’$52.8M
Returns
Return on capital โ€” โ€” โ€” โˆ’229.1% โˆ’315.3% โˆ’556.6% โ€”
Return on capital employed โ€” โˆ’26.1% โˆ’29.1% โˆ’60.8% โˆ’53.4% โˆ’99.2% 478.1%
Return on equity โ€” โˆ’72.6% โˆ’29.8% โˆ’39.3% โˆ’58.2% โˆ’81.5% โˆ’565.3%
Return on assets โ€” โˆ’29.7% โˆ’28.4% โˆ’36.7% โˆ’50.1% โˆ’63.4% โˆ’135.8%
Return on tangible equity โ€” โˆ’30.7% โˆ’25.2% โˆ’50.5% โˆ’52.5% โˆ’100.3% โ€”
Growth
Share count change โ€” 127.3% 135.4% 6.1% 20.2% 32.2% 38.6%
Financial health
Debt / equity โ€” โ€” โ€” 0.0x 0.1x 0.2x โ€”
Interest coverage โ€” โ€” โ€” โ€” โˆ’62.1x โˆ’39.8x โˆ’39.6x
Current ratio โ€” 29.4x 19.5x 12.3x 13.3x 5.9x 0.8x
Quick ratio โ€” 29.4x 19.5x 12.3x 13.3x 5.9x 0.8x
Quality scores
Piotroski F-score โ€” โ€” โ€” โ€” 3.0 1.0 1.0
Altman Z'' โ€” 33.0 20.5 9.7 2.6 โˆ’5.9 โˆ’20.4
Accruals ratio โ€” โˆ’9.3% โˆ’1.6% 5.6% โˆ’8.9% โˆ’14.7% โˆ’61.6%

Source: SEC EDGAR XBRL filings (CIK 0001816590). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ€” not investment advice. Check the original filings before relying on any figure.

โ†‘ โ†“ to move ยท โ†ต to open